Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 60.89
+0.90 (1.50%)
Apr 21, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 7.91 billion as of April 21, 2026. Its market cap has decreased by -0.26% in one year.
Market Cap
7.91B
Enterprise Value
6.89B
Revenue
1.20B
Ranking
n/a
PE Ratio
34.93
Stock Price
60.89
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 7.91B, an increase of 30.14%. That is a compound annual growth rate of 4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 7.80B | -16.98% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 8.34B |
| Daan Gene | 8.29B |
| Jiangsu Aidea Pharmaceutical Group | 8.15B |
| Acrobiosystems | 8.05B |
| Suzhou Fengbei Biotech Stock | 7.75B |
| GemPharmatech | 7.73B |
| Nanjing Vazyme Biotech | 7.50B |
| Shanghai OPM Biosciences | 7.26B |